Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Feb 27, 2024 2:52pm
RE:RE:RE:RE:PRC Partners (June 2022)
I didn't say it was a "scam", so stop the fraudulent accusations. But can you honestly say you didn't expect SOMETHING from AbbVie by now? And I repeat; HONESTLY.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Feb 27, 2024 2:16pm
RE:RE:RE:PRC Partners (June 2022)
I'm curious. How do you know for sure that Abbvie TFC-1067 is a scam?
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Feb 27, 2024 1:59pm
RE:RE:RE:PRC Partners (June 2022)
It really is disgusting how mismanaged this whole thing has been over the years. If the Rodan and Fields fiasco wasn't bad enough, now it does look like the AbbVie "deal" was another
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Feb 27, 2024 1:28pm
RE:RE:PRC Partners (June 2022)
Yes, Tyler, we paid for a lot of Sirona BS. Maybe the launch of the latest product for early 2025 will end up like the TFC1067 AbbVie scam job at the hands of someone that nobody trusts for a second.
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Feb 27, 2024 11:35am
RE:PRC Partners (June 2022)
And we paid for that bs?
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Feb 27, 2024 10:51am
RE:PRC Partners (June 2022)
2022 it is now 2024 - that forecast did not work out that well did it?
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Feb 27, 2024 10:21am
PRC Partners (June 2022)
takes a little longer, huh? PRC Partner statement from June 2022: AbbVie is already in the advanced stages of its development and commercialization process for TFC-1067. While we agree with the
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Feb 26, 2024 9:35am
RE:RE:RE:Short position - lowest ever
No one with half a brain would short a 9-cent stock that trades such low volume. Any shorts you see would probably be associated with one of the sweet-heart financing deals, just like the big ask we
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Feb 25, 2024 10:57pm
RE:RE:Short position - lowest ever
not many retail shorting while the share price is hopping in and out of the sewers. individual wait until it pops. then short.
(28)
•••
zerbo
X
View Profile
View Bullboard History
Comment by
zerbo
on Feb 25, 2024 10:10am
RE:Short position - lowest ever
Saw this 2 days ago, the last time it was lower was in 2017 and got me really my head scratching. So I'm asking myself, should I just chill or .... ??
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Feb 24, 2024 3:36pm
Short position - lowest ever
Now dropped to a meagre 48 shares. This is one of the lowest I have seen. https://ceo.ca/sbm
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Feb 23, 2024 7:19am
RE:Experts Say Quiet Luxury Skin Is the Next Major Face Trend
Nice find Nitro! What I take away from this is " the frozen look" typically produced by Botox and other invasive treatments. 1326 is absolutely a shoe in solution to fill this emerging
...more
(7)
•••
Nitrodouglas
X
View Profile
View Bullboard History
Post by
Nitrodouglas
on Feb 22, 2024 7:45pm
Experts Say Quiet Luxury Skin Is the Next Major Face Trend
https://www.popsugar.co.uk/beauty/quiet-luxury-natural-skin-trend-49338316?utm_source=dash+hudson&utm_medium=instagramuk&utm_campaign=likeshopme
(2136)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 21, 2024 2:16pm
RE:RE:New Press Release - Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim(TM) in Early 2025
Europe mkt as big as NA, so double slide 21 revenue forecast of $21 million to $42 million
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >